Latest research on IgG4 disease – differentials between permutations of infected and uninfected, unvaxxed then vexxed “mix and match” injections – the booster is the big “switcher”
A discussion of this paper on the role of IGg4 in cancer.
From this 33 minute video here:
IgG4 role in cancer - Dr. Raszek new publication (IgG4 part 17, update #147) (youtube.com)
IgG4 role in cancer - Dr. Raszek new publication (IgG4 part 17, update #147)
15,598 views Premiered 18 hours ago Turbo cancers
We go over the first published review summarizing collective scientific literature on IgG4 development in mRNA-vaccinated individuals which is Dr. Raszek’s own review.
The additional focus of this review is to bring attention to how IgG4 antibodies play a role in cancer development. What we cover: *Summary of when mRNA vaccinated do not produce IgG4 antibodies *Summary of how IgG4 antibodies are produced in mRNA-vaccinated *Background on how IgG4 are seen in cancers *Review of turbo cancers (called hyperprogressive disease) *How IgG4/IgG ratio or IgG4 B cells could be biomarkers of cancer outcomes *What are tumor suppressor proteins and oncogenic proteins *Background on how galectin-3 plays a role in cancer *How spike protein mimicry of galectin-3 could be a factor in cancer development Location: Horsethief Canyon, Alberta Described content: https://www.explorationpub.com/Journa...
The study shows that some people are protected from the impact of IgG4 disease.
· Never vexxed do not produce IgG4.
· Adenovirus/protein based injections do not produce these antibodies (AN, Sputnik and Novavax
· Infected first then injected – protected from IgG4
· Taking certain immune suppressants = protection gained
· One mRNA and then one adenovirus seems to protect
Not known if more injections removes protection.
Too much antigen exposure is a root cause. Too much spike protein = more IgG4 in Moderna?
Stay for the talk about Gelactin3 which has much in common with “chopped up” spike protein – which apparently is now well recognised and isolated!
Here’s some research from 2017 on Galectin-3 and IgG4:
“Immunoglobulin G4-related disease (IgG4-RD) is a multiorgan condition manifesting itself in different forms. This study aimed to investigate protein expression profiles and to find the possible biomarker for IgG4-RD by liquid chromatography mass spectrometry (LC-MS) using tissue sections in IgG4-RD patients.
“LC-MS indicated that the levels of 17 proteins were significantly higher and 12 others were significantly lower in IgG4-related pancreatitis patients compared to controls. Among these proteins, galectin-3 levels were 13-fold higher in IgG4-related pancreatitis (P < 0.01).”
Onwards!!!
Please take a paid subscription or forward this article to those you think might be interested. You can also donate via Ko-fi – any amount from three dollars upwards. Ko-fi donations here: https://ko-fi.com/peterhalligan